Join Us for i3 2026: Unveiling Innovations in BioPharma Data Management
IDBS, renowned for its cloud software tailored for BioPharma organizations, proudly announces the upcoming i3 2026 event, scheduled for May 18, 2026, in Boston, USA. Following the remarkable success of i3 2025, this prestigious gathering will once again bring together customers, partners, and industry leaders to focus on data management innovations.
The i3 event, which stands for Innovation, Ideas, and Insight, is centered on fostering collaboration and igniting fresh ideas within the ever-evolving BioPharma sector. The previous edition, i3 2025, held on September 23-24 at IDBS's headquarters in Woking, UK, drew significant attention from experts, showcasing the latest advancements in scientific data management, artificial intelligence (AI), and digital transformation.
During the two-day event, participants engaged in strategic discussions, technical presentations, and customer-led showcases that illuminated the transformative impact of IDBS solutions. Notable presentations from companies such as KBI Biopharma, IQVIA Laboratories, and Eisai Co., Ltd. propelled the conversation on how IDBS platforms deliver quantifiable business value throughout the research and development lifecycle. Attendees were particularly impressed with innovations like near real-time client data portals, optimized scientific workflows, and next-generation GxP validation.
One of the highlights of the gathering was the launch of a new cloud-native integration framework that features a connector for Cytiva's UNICORN software integrated with the IDBS Polar Platform. This advancement enhances end-to-end workflows and brings chromatography data into the forefront as actionable insights. BI experts also led breakout sessions sharing their strategies on making data AI-ready, demonstrating ROI to gain internal support, and utilizing structured process knowledge to encourage AI-driven execution in BioPharma.
Panel discussions featuring specialists from IQVIA and Phillips Medisize addressed critical topics such as GxP compliance, digital validation, and data integrity, equipping attendees with practical knowledge applicable in regulated environments.
In addition to the informative sessions, the i3 Gala Dinner celebrated excellence in scientific data management. Six exceptional organizations were acknowledged for their contributions: Boehringer Ingelheim earned the IDBS Unsung Hero / MVP award, while GSK won the Design Partnership Champion award. KBI Biopharma received recognition for the Best Use Case of Data Out, IQVIA Laboratories was awarded for the Best Workflow in Bioanalysis, and Phillips Medisize took home two awards for Best ROI Generating Workflow and Best Poster.
Looking forward, IDBS is already in the planning stages for i3 2026, eager to welcome participants to Boston for another compelling session focused on the future of BioPharma data and innovation. Registration is now open for all IDBS software users at IDBS's website.
About IDBS:
IDBS is committed to revolutionizing the way BioPharma organizations utilize AI and machine learning to enhance patient outcomes. Trusted by 80% of the world's leading BioPharma companies, IDBS provides advanced cloud software and services designed to meet the progressive demands of the industry. With a legacy of 35 years in scientific informatics, IDBS helps organizations streamline processes, manage data, and achieve insightful outcomes throughout product lifecycles. Their flagship IDBS E-WorkBook software, alongside the expanded capabilities of IDBS Polar and PIMS cloud platforms, empowers scientists to make informed decisions confidently in both GxP and non-GxP environments. Discover more about IDBS at their official site.
The i3 event, which stands for Innovation, Ideas, and Insight, is centered on fostering collaboration and igniting fresh ideas within the ever-evolving BioPharma sector. The previous edition, i3 2025, held on September 23-24 at IDBS's headquarters in Woking, UK, drew significant attention from experts, showcasing the latest advancements in scientific data management, artificial intelligence (AI), and digital transformation.
During the two-day event, participants engaged in strategic discussions, technical presentations, and customer-led showcases that illuminated the transformative impact of IDBS solutions. Notable presentations from companies such as KBI Biopharma, IQVIA Laboratories, and Eisai Co., Ltd. propelled the conversation on how IDBS platforms deliver quantifiable business value throughout the research and development lifecycle. Attendees were particularly impressed with innovations like near real-time client data portals, optimized scientific workflows, and next-generation GxP validation.
One of the highlights of the gathering was the launch of a new cloud-native integration framework that features a connector for Cytiva's UNICORN software integrated with the IDBS Polar Platform. This advancement enhances end-to-end workflows and brings chromatography data into the forefront as actionable insights. BI experts also led breakout sessions sharing their strategies on making data AI-ready, demonstrating ROI to gain internal support, and utilizing structured process knowledge to encourage AI-driven execution in BioPharma.
Panel discussions featuring specialists from IQVIA and Phillips Medisize addressed critical topics such as GxP compliance, digital validation, and data integrity, equipping attendees with practical knowledge applicable in regulated environments.
In addition to the informative sessions, the i3 Gala Dinner celebrated excellence in scientific data management. Six exceptional organizations were acknowledged for their contributions: Boehringer Ingelheim earned the IDBS Unsung Hero / MVP award, while GSK won the Design Partnership Champion award. KBI Biopharma received recognition for the Best Use Case of Data Out, IQVIA Laboratories was awarded for the Best Workflow in Bioanalysis, and Phillips Medisize took home two awards for Best ROI Generating Workflow and Best Poster.
Looking forward, IDBS is already in the planning stages for i3 2026, eager to welcome participants to Boston for another compelling session focused on the future of BioPharma data and innovation. Registration is now open for all IDBS software users at IDBS's website.
About IDBS:
IDBS is committed to revolutionizing the way BioPharma organizations utilize AI and machine learning to enhance patient outcomes. Trusted by 80% of the world's leading BioPharma companies, IDBS provides advanced cloud software and services designed to meet the progressive demands of the industry. With a legacy of 35 years in scientific informatics, IDBS helps organizations streamline processes, manage data, and achieve insightful outcomes throughout product lifecycles. Their flagship IDBS E-WorkBook software, alongside the expanded capabilities of IDBS Polar and PIMS cloud platforms, empowers scientists to make informed decisions confidently in both GxP and non-GxP environments. Discover more about IDBS at their official site.
Topics Business Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.